-+ 0.00%
-+ 0.00%
-+ 0.00%

Skye Bioscience CEO presents nimacimab-GLP-1 obesity combination strategy at GLP-1 therapeutics summit

Reuters·04/07/2026 11:04:29

Please log in to view news